Paul Hutton1, Samantha Bowe, Sophie Parker, Sarah Ford. 1. Psychosis Research Unit (PRU) Early Detection and Intervention Team (EDIT), Greater Manchester West Mental Health Foundation NHS Trust, Bury New Road, Prestwich, Manchester, UK. paulhutton@nhs.net
Abstract
BACKGROUND: Little data is available on the prevalence of suicide risk factors in people at ultra-high risk (UHR) of developing psychosis. AIM: The aim of this study was to provide an estimate of the cross-sectional prevalence of possible suicide risk factors in those attending a routine clinical service for people at UHR of developing psychosis. METHODS: For all patients in treatment (n=34) over a 4-week period, levels of suicidal ideation and depression upon entry to the service were assessed by auditing intake scores on the Beck Depression Inventory, second edition. Level of engagement with services, social isolation, substance and alcohol misuse, ready access to means, current suicidal ideation, previous suicide attempts, current or previous self-harm, expressions of concern from others, depression, agitation, hopelessness, worthlessness, suspiciousness and fears of mental disintegration were all assessed by case note review and interview with the treating clinician. RESULTS: There was a high prevalence of at least mild suicidal ideation (58.8%, n=20) and severe depressed mood (47%, n=16) in this client group at point of entry to the service. Seven people (20.6%) had engaged in serious self-harm (including attempted suicide) during the time they were in contact with the service. Forty-seven per cent (n=16) reported at least 27 suicide attempts between them; the mean number of attempts being 1.69 (standard deviation=1.08). CONCLUSION: Suicide risk was high in this small sample of people at UHR of developing psychosis. Controlled research with larger samples and better methodology is urgently required to inform legal, ethical and scientific debates surrounding this group.
BACKGROUND: Little data is available on the prevalence of suicide risk factors in people at ultra-high risk (UHR) of developing psychosis. AIM: The aim of this study was to provide an estimate of the cross-sectional prevalence of possible suicide risk factors in those attending a routine clinical service for people at UHR of developing psychosis. METHODS: For all patients in treatment (n=34) over a 4-week period, levels of suicidal ideation and depression upon entry to the service were assessed by auditing intake scores on the Beck Depression Inventory, second edition. Level of engagement with services, social isolation, substance and alcohol misuse, ready access to means, current suicidal ideation, previous suicide attempts, current or previous self-harm, expressions of concern from others, depression, agitation, hopelessness, worthlessness, suspiciousness and fears of mental disintegration were all assessed by case note review and interview with the treating clinician. RESULTS: There was a high prevalence of at least mild suicidal ideation (58.8%, n=20) and severe depressed mood (47%, n=16) in this client group at point of entry to the service. Seven people (20.6%) had engaged in serious self-harm (including attempted suicide) during the time they were in contact with the service. Forty-seven per cent (n=16) reported at least 27 suicide attempts between them; the mean number of attempts being 1.69 (standard deviation=1.08). CONCLUSION: Suicide risk was high in this small sample of people at UHR of developing psychosis. Controlled research with larger samples and better methodology is urgently required to inform legal, ethical and scientific debates surrounding this group.
Authors: Paolo Fusar-Poli; Stefan Borgwardt; Andreas Bechdolf; Jean Addington; Anita Riecher-Rössler; Frauke Schultze-Lutter; Matcheri Keshavan; Stephen Wood; Stephan Ruhrmann; Larry J Seidman; Lucia Valmaggia; Tyrone Cannon; Eva Velthorst; Lieuwe De Haan; Barbara Cornblatt; Ilaria Bonoldi; Max Birchwood; Thomas McGlashan; William Carpenter; Patrick McGorry; Joachim Klosterkötter; Philip McGuire; Alison Yung Journal: JAMA Psychiatry Date: 2013-01 Impact factor: 21.596
Authors: Kelly E Gill; Jean M Quintero; S Lucy Poe; Alvaro D Moreira; Gary Brucato; Cheryl M Corcoran; Ragy R Girgis Journal: Schizophr Res Date: 2015-05-07 Impact factor: 4.939
Authors: M Jarrett; L Valmaggia; J Parrott; A Forrester; T Winton-Brown; H Maguire; D Ndegwa; P McGuire; T K J Craig Journal: Epidemiol Psychiatr Sci Date: 2015-03-03 Impact factor: 6.892
Authors: Margaux M Grivel; Wei Leong; Michael D Masucci; Rebecca A Altschuler; Leigh Y Arndt; Samantha L Redman; Lawrence H Yang; Gary Brucato; Ragy R Girgis Journal: Schizophr Res Date: 2017-09-19 Impact factor: 4.939
Authors: Jordan E DeVylder; Amy J Oh; Shelly Ben-David; Neyra Azimov; Jill M Harkavy-Friedman; Cheryl M Corcoran Journal: Schizophr Res Date: 2012-07-28 Impact factor: 4.939
Authors: Joseph S DeLuca; Nicole D Andorko; Doha Chibani; Samantha Y Jay; Pamela J Rakhshan Rouhakhtar; Emily Petti; Mallory J Klaunig; Elizabeth C Thompson; Zachary B Millman; Kathleen M Connors; LeeAnn Akouri-Shan; John Fitzgerald; Samantha L Redman; Caroline Roemer; Miranda A Bridgwater; Jordan E DeVylder; Cheryl A King; Steven C Pitts; Shauna P Reinblatt; Heidi J Wehring; Kristin L Bussell; Natalee Solomon; Sarah M Edwards; Gloria M Reeves; Robert W Buchanan; Jason Schiffman Journal: J Psychother Integr Date: 2020-06
Authors: Ragy R Girgis; Rakshathi Basavaraju; Jeanelle France; Melanie M Wall; Gary Brucato; Jeffrey A Lieberman; Frank A Provenzano Journal: Psychiatry Res Neuroimaging Date: 2021-04-07 Impact factor: 2.493
Authors: Christy Hui; Carmen Morcillo; Debra A Russo; Jan Stochl; Gillian F Shelley; Michelle Painter; Peter B Jones; Jesus Perez Journal: Schizophr Res Date: 2013-06-14 Impact factor: 4.939